CT Gastrointestinal Bleed: 3 Critical Imaging Phases for Detecting Active Hemorrhage
At a Glance: CT Gastrointestinal Bleed Protocol
| Tube Voltage (kVp) | 120 kVp |
| Pitch | 1.0 |
| Tube Current (mA) | 200–300 mA (with automatic exposure control) |
| Rotation Time | 0.5 seconds |
| Contrast Volume | 100 mL (iodine concentration 350–370 mgI/mL) |
| Flow Rate | 4.0 mL/s |
| Saline Chaser | 100 mL |
| Phase Sequence | Non-contrast → Arterial (bolus tracked) → Portal venous (70 s fixed delay) |
| Key HU Range | Active extravasation: +85 to +350 HU, increasing in size and shifting between phases |
| Primary Scanning Pitfall | Omitting the baseline non-contrast phase |
| Primary Interpretation Pitfall | Misreading retained high-density fluid as active bleeding on a single-phase scan |
Table of Contents
- Introduction: Why Multiphase CT Is the First-Line Test for GI Bleeding
- Anatomy & Hounsfield Unit Values
- Scanning Technique: 7 Steps to a Diagnostic Study
- Contrast Media Protocol
- Radiation Dose Management
- Top 10 Pathologies on CT Gastrointestinal Bleed Studies
- Pitfalls — Radiographers’ Perspective
- Pitfalls — Radiologists’ Perspective
- Pitfalls — Non-Radiology Physicians’ Perspective
- Pitfall Comparison Summary
- AI & Automation in GI Bleed Imaging
- Further Reading
- Conclusion
- References
Introduction: Why Multiphase CT Is the First-Line Test for GI Bleeding
A well-executed CT gastrointestinal bleed protocol has become the frontline imaging study for hemodynamically significant hemorrhage anywhere along the digestive tract. Acute gastrointestinal bleeding remains one of the most common causes of emergency hospital admission, and although the majority of episodes resolve with conservative management, a meaningful minority progress to massive hemorrhage, hypovolemic shock, and death if the bleeding source is not localized quickly[1][2]. Endoscopy remains the diagnostic and therapeutic mainstay for upper and lower tract bleeding, but it is frequently limited by poor visualization in an unprepped, actively hemorrhaging bowel, and it cannot reach the mid small bowel without specialized enteroscopy. This is where a properly timed, multiphase CT examination earns its place as the gatekeeper test that triages patients toward endoscopy, interventional embolization, or surgery.
Clinical context callout: A 68-year-old patient presents with hematochezia, a falling hemoglobin, and tachycardia. The emergency physician needs an answer within minutes, not hours: is there active extravasation, and if so, where? A correctly sequenced non-contrast, arterial, and portal venous acquisition can answer both questions in a single visit to the scanner, directing the interventional radiology team to the precise vascular territory before the patient becomes hemodynamically unstable.
The diagnostic premise of CT for gastrointestinal hemorrhage is deceptively simple: contrast material that is actively leaking from a damaged vessel into the bowel lumen will appear as a focus of high attenuation that was not present on the non-contrast images, that enhances on the arterial phase, and that characteristically increases in size, blooms, or migrates with bowel peristalsis on the delayed portal venous phase. This temporal behavior — a finding present on one phase, evolving on the next, and absent at baseline — is what separates true active bleeding from a host of mimics, and it is precisely why every phase in this three-acquisition protocol carries diagnostic weight. Detection thresholds for CT are reported in the range of 0.3 to 0.5 mL per minute, comparable to catheter angiography and considerably more sensitive than tagged red blood cell scintigraphy for localization purposes[3].
This article walks radiographers, radiologists, and the emergency physicians and surgeons who order these studies through every component of the modern CT gastrointestinal bleed protocol: scan timing, contrast pharmacokinetics, dose optimization, the ten pathologies most frequently encountered, and — critically — the pitfalls at each stage of the imaging chain that can turn a life-saving test into a missed or falsely positive diagnosis.
Anatomy & Hounsfield Unit Values
Gastrointestinal bleeding can originate anywhere from the gastroesophageal junction to the anal verge, and the imaging approach must account for the full length of this tract along with its overlapping arterial supplies. The upper gastrointestinal tract (esophagus, stomach, duodenum) is perfused predominantly by the celiac axis; the mid tract (jejunum, ileum) by the superior mesenteric artery (SMA); and the lower tract (colon, rectum) by a combination of the SMA and inferior mesenteric artery (IMA), with rich collateral anastomoses through the marginal artery of Drummond and the arc of Riolan. Because roughly 50% of bleeding episodes originate in the upper tract, 40% in the lower tract, and the remaining 10% in the small bowel[4], the CT field of view must extend from the diaphragm through the inferior pubic rami on every acquisition to avoid missing a source outside the clinically suspected segment.
| Structure / Finding | Typical HU Range | Notes |
|---|---|---|
| Normal bowel wall (unenhanced) | +20 to +45 HU | Mild, uniform mural enhancement on portal venous phase |
| Aorta, non-contrast baseline | +35 to +55 HU | Reference point for bolus tracking ROI placement |
| Aortic lumen, arterial phase | +250 to +400 HU | Confirms adequate arterial opacification |
| Active extravasation, arterial phase | +85 to +350 HU | Focal, ill-defined; intraluminal or pooling within bowel |
| Active extravasation, portal venous phase | Increases relative to arterial phase | Enlarging or shifting pool confirms active rather than static bleeding |
| Retained oral medication / pill fragment | +200 to +1000+ HU | Present on non-contrast baseline — key differentiator |
| Surgical clip / suture material | >1000 HU, blooming artifact | Metallic, geometric, present at baseline |
| Fecalith / coprolith | +90 to +200 HU | Layered, mixed-density, located within formed stool |
| Hemoperitoneum (acute) | +30 to +45 HU | “Sentinel clot” sign may localize adjacent bleeding source |
| Pneumatosis intestinalis | Air density, −600 to −1000 HU | Mimicker of ischemic, not hemorrhagic, pathology |
Gross anatomic review for this protocol begins with the bowel wall itself, which under normal physiologic conditions demonstrates a thin, symmetric, mildly enhancing mucosal stripe on the portal venous phase. The mesenteric vasculature — celiac trunk, SMA, IMA, and their branches — should be evaluated on every study because vascular anomalies such as a replaced right hepatic artery or an accessory left gastric artery can alter the expected bleeding territory and influence subsequent angiographic planning. The portal and mesenteric venous system must also be assessed, since variceal bleeding from portal hypertension presents a fundamentally different hemorrhage pattern (dilated, serpiginous submucosal vessels rather than a focal blush) requiring a distinct management pathway.
Relevant clinical anatomy: small bowel and colon
The small bowel measures roughly six to seven meters in the adult and is the most diagnostically challenging segment because of its mobility and redundant looping, which can obscure or displace a small bleeding focus between phases if the patient moves on the table. The colon, by contrast, occupies a relatively fixed retroperitoneal and peritoneal course, making diverticular disease of the sigmoid and right colon — the single most common cause of lower gastrointestinal hemorrhage in adults over 60 — comparatively easier to localize once a focus of extravasation is identified within a diverticular outpouching.
Standardize Your GI Bleed Imaging Pathway
Equip your CT suite with workflow tools built for rapid, multiphase abdominal protocols.
Scanning Technique: 7 Steps to a Diagnostic Study
- Patient preparation and positioning. Position the patient supine, arms elevated above the head when tolerated to minimize beam-hardening streak artifact across the upper abdomen. Establish a large-bore (18-gauge or larger) antecubital IV line capable of sustaining the required 4.0 mL/s flow rate; a smaller-gauge or hand/wrist line risks extravasation or an inadequate bolus.
- Acquire the non-contrast baseline series. Scan the entire abdomen and pelvis from the diaphragm to below the inferior pubic rami without contrast. This phase exists for one purpose: to document any pre-existing high-density material (retained barium, pills, surgical clips, vascular calcification) so it is not mistaken for extravasated contrast on the later phases.
- Plan the bolus-tracking region of interest. Place the tracking ROI within the abdominal aorta at the level of the celiac axis, with a triggering threshold and an additional diagnostic delay (typically 6–8 seconds post-threshold) to ensure full arterial opacification before acquisition begins.
- Inject and acquire the arterial phase. Administer 100 mL of contrast at 4.0 mL/s followed by a 100 mL saline chaser to maintain bolus geometry and reduce streak artifact from undiluted contrast in the central veins. Acquire from diaphragm to pubic symphysis immediately upon trigger.
- Acquire the portal venous phase at a fixed 70-second delay. Time this acquisition from the start of contrast injection. The 70-second window allows maximal parenchymal and bowel wall enhancement while still falling early enough in the venous cycle to capture an enlarging or migrating pool of extravasated contrast relative to the arterial phase images.
- Reconstruct thin-section and multiplanar datasets. Generate 0.625–1.0 mm axial reconstructions plus coronal and sagittal multiplanar reformats for all three phases; coronal reformats are particularly valuable for tracing a tubular structure such as a loop of jejunum or the sigmoid colon along its long axis.
- Perform side-by-side phase comparison before the patient leaves the table. Review all three phases together in real time. If a candidate focus of extravasation is identified but its behavior across phases is ambiguous, consider an additional delayed acquisition (90–120 seconds) before releasing the patient, since true active bleeding should continue to evolve.
Scanner generation comparison: 16-slice to 320-slice systems
| Scanner Class | Rotation Time | Practical Implication for GI Bleed Protocol |
|---|---|---|
| 16-slice MDCT | 0.5–0.75 s | Adequate for the protocol but longer total acquisition time increases risk of phase misregistration from peristalsis; meticulous breath-hold coaching required |
| 64-slice MDCT | 0.4–0.5 s | Current institutional workhorse; reliably captures the full abdomen and pelvis within a single breath-hold per phase |
| 128–256-slice MDCT | 0.27–0.4 s | Shorter acquisition window reduces motion and peristalsis artifact; supports finer 0.5 mm collimation for small-vessel detail |
| 320-slice (wide-detector) CT | 0.27–0.35 s | Can cover the entire abdomen in a single rotation in select systems, virtually eliminating stitching artifact across detector boundaries during active hemorrhage |
Dual-energy and photon-counting CT protocols for GI bleed
| Technology | Protocol Adjustment | Diagnostic Benefit |
|---|---|---|
| Dual-energy CT (DECT) | Single portal venous acquisition with virtual non-contrast (VNC) reconstruction | Can substitute for the true non-contrast phase in select protocols, lowering total radiation dose while distinguishing iodine from calcium or high-density retained material via material decomposition |
| Dual-energy CT — iodine overlay maps | Generate iodine-only images at the portal venous phase | Increases conspicuity of subtle, low-volume extravasation that may be obscured by background bowel attenuation on standard mixed images |
| Photon-counting CT (PCCT) | Ultra-low-dose virtual monoenergetic non-contrast equivalent plus high-resolution arterial/venous phases | Improved spectral separation and reduced electronic noise allow detection of lower-volume bleeding with a meaningfully reduced radiation burden compared with conventional energy-integrating detectors |
Deep learning reconstruction (DLR)
Deep learning reconstruction algorithms are increasingly deployed across all three phases of this protocol. By training neural networks on raw projection data to suppress quantum noise while preserving edge sharpness, DLR allows tube current to be reduced without the textural mottling associated with traditional iterative reconstruction. For a multiphase examination acquired three times in rapid succession, this noise reduction is clinically meaningful: it preserves the conspicuity of a small, low-attenuation bleeding focus against bowel content while keeping the cumulative dose of the three-phase study within acceptable diagnostic reference levels.
Contrast Media Protocol
The contrast strategy for a CT gastrointestinal bleed study is built around three sequential phases, each interrogating a different physiologic window. A total of 100 mL of iodinated contrast (350–370 mgI/mL concentration is preferred to maximize peak intraluminal attenuation) is administered at 4.0 mL/s, immediately followed by a 100 mL saline chaser delivered at a matched or near-matched rate. The saline chaser pushes the trailing contrast column out of the peripheral vein and central veins, both reducing dense-contrast streak artifact across the SVC and right atrium on the arterial phase and ensuring that the full contrast bolus reaches the arterial circulation rather than remaining sequestered in the injection tubing and proximal vein.
| Phase | Timing | Purpose |
|---|---|---|
| Non-contrast | Baseline, no trigger | Exclude pre-existing high-density mimics (pills, clips, fecaliths, calcification) |
| Arterial | Bolus tracked, abdominal aorta ROI | Detect peak-attenuation active extravasation and characterize arterial anatomy/aneurysms |
| Portal venous | 70 s fixed delay from injection start | Confirm true active bleeding by demonstrating an enlarging or migrating contrast pool relative to the arterial phase; assess solid organ and bowel wall enhancement |
Safety check callout: Because this protocol relies on a full 100 mL iodinated bolus delivered at a relatively high 4.0 mL/s flow rate, renal function (eGFR) and any history of prior contrast reaction must be confirmed before injection, consistent with current contrast media safety guidelines[5]. In hemodynamically unstable patients with active hemorrhage, the clinical urgency of source localization is generally judged to outweigh a moderate contrast-induced nephropathy risk, but this risk-benefit decision should be documented per institutional protocol.
Patients with suspected variceal bleeding from portal hypertension represent a special case: because the source vessels are venous rather than arterial, the diagnostic information is concentrated in the portal venous phase, and some institutions extend the protocol with a delayed (90–120 second) acquisition to capture slower-filling varices or to confirm a subtle arterial finding seen on the standard arterial phase. Aortoenteric fistula, a rare but immediately life-threatening cause of massive upper or mid-tract hemorrhage in patients with a history of aortic graft surgery, similarly benefits from careful arterial-phase evaluation of the graft-bowel interface for loss of the normal fat plane or direct contrast extravasation into an adjacent bowel loop.
Precision Injection for Time-Critical Bleeds
Consistent 4.0 mL/s delivery and reliable bolus geometry matter most when seconds count.
Radiation Dose Management
A three-phase abdominal and pelvic CT examination carries a meaningfully higher cumulative radiation dose than a routine single-phase study, which makes deliberate dose optimization a clinical priority rather than an afterthought — particularly given that many GI bleed patients are elderly and may require serial follow-up imaging during a single hospitalization.
| Parameter | Typical Diagnostic Reference Level (per phase) |
|---|---|
| CTDIvol | 10–16 mGy |
| DLP (abdomen + pelvis) | 500–750 mGy·cm |
| Effective dose (per phase) | 7.5–11 mSv |
| SSDE (average adult) | 12–18 mGy |
Across the full three-phase protocol, cumulative effective dose typically falls in the range of 20–30 mSv, underscoring the importance of restricting acquisition to the necessary three phases and avoiding an unindicated fourth or fifth pass.
Five dose reduction strategies
- Automatic exposure control (AEC) / automatic tube current modulation across all three phases, allowing the system to lower mA over thinner body regions such as the pelvis relative to a larger upper abdomen.
- Iterative or deep learning reconstruction to permit lower tube current without sacrificing the conspicuity of a small extravasation focus against image noise.
- Virtual non-contrast (VNC) substitution via dual-energy CT in select protocols, eliminating the true non-contrast acquisition entirely and removing roughly one-third of the total dose.
- Tailored kVp selection using automated tube voltage selection software, which can reduce kVp below 120 in smaller patients while preserving iodine contrast-to-noise ratio.
- Strict scan-range discipline, limiting the craniocaudal coverage to diaphragm through inferior pubic rami rather than extending unnecessarily into the thorax or lower extremities.
These strategies align with the dose optimization principles set out in European Commission Radiation Protection report RP 185, the American Association of Physicists in Medicine (AAPM) CT dose reporting guidance, and the International Commission on Radiological Protection (ICRP) framework for justification and optimization in medical imaging[6][7].
Cut Cumulative Multiphase Dose Without Losing Diagnostic Confidence
See how modern dose-tracking and reconstruction tools support justified, optimized GI bleed protocols.
Top 10 Pathologies on CT Gastrointestinal Bleed Studies
Active Diverticular Hemorrhage
+85 to +300 HU focal blush within a colonic diverticulum, most commonly right-sided. Protocol impact: the portal venous phase is essential to confirm an enlarging pool, since diverticular bleeding is frequently intermittent and may appear static on a single-phase arterial-only acquisition.
Angiodysplasia / Arteriovenous Malformation (AVM)
Subtle, low-volume blush often under +150 HU, frequently located in the cecum or ascending colon. Protocol impact: thin-section reconstruction and iodine-overlay dual-energy imaging substantially improve detection of these typically small, low-flow lesions.
Angioma
Well-circumscribed mucosal or submucosal vascular lesion demonstrating early, intense arterial enhancement (+150 to +250 HU) that may persist into the venous phase. Protocol impact: requires correlation with endoscopic findings, as angiomas can mimic the appearance of low-grade malignancy.
Dieulafoy’s Lesion
A submucosal arteriole, classically gastric, producing brisk, high-attenuation extravasation (+200 to +350 HU) disproportionate to its small mucosal defect. Protocol impact: rapid hemodynamic compromise is common; immediate interventional radiology notification is warranted upon detection.
Peptic Ulcer Hemorrhage
Focal extravasation along the lesser curvature of the stomach or duodenal bulb, often +100 to +250 HU. Protocol impact: adjacent perigastric fat stranding and a thickened, ulcerated wall support the diagnosis and help distinguish active bleeding from post-endoscopic clip artifact.
Bleeding Colorectal Polyp
Pedunculated or sessile intraluminal mass with an adjacent or surface focus of contrast pooling. Protocol impact: coronal reformats help trace the polyp stalk and confirm the bleeding point is mucosal rather than a separate vascular lesion.
Meckel’s Bleed
Hemorrhage from ectopic gastric mucosa within a Meckel diverticulum, typically in the distal ileum. Protocol impact: this segment is easily overlooked on routine review; deliberate small-bowel tracing on coronal images is required, particularly in younger patients with painless lower GI bleeding.
Post-Polypectomy Bleeding
Focal extravasation at a recent endoscopic resection site, occasionally complicated by an adjacent hematoma. Protocol impact: prior endoscopy reports should be reviewed before the study to correctly localize the resection site and avoid confusing post-procedural clip artifact with active bleeding.
Aortoenteric Fistula
Loss of the normal fat plane between an aortic graft and adjacent bowel, with possible direct extraluminal gas or contrast tracking into the bowel lumen. Protocol impact: a surgical emergency; arterial-phase images of the graft-bowel interface must be scrutinized in any patient with a history of aortic reconstruction presenting with GI hemorrhage.
Variceal Bleeding
Dilated, serpiginous submucosal venous structures, most often esophageal or gastric, best assessed on the portal venous phase. Protocol impact: portal vein patency and the presence of cirrhotic liver morphology should be specifically reported, as management diverges substantially from arterial-source bleeding.
Build a Reliable Pathology Recognition Workflow
Standardized protocols help your team catch low-volume bleeds before they become emergencies.
Pitfalls — Radiographers’ Perspective
The single most consequential scanning pitfall in this protocol is failing to include the baseline non-contrast phase. Without a true unenhanced acquisition, a radiographer and the interpreting radiologist have no reliable way to distinguish high-density retained pills, fecaliths, or surgical clips from genuine active extravasation, since all three can present as focal areas of elevated attenuation on a contrast-only study.
| Category | Description | Mitigation |
|---|---|---|
| Protocol omission | Skipping the non-contrast phase under time pressure in an unstable patient | Build the non-contrast acquisition into the protocol as a mandatory, non-skippable step in the scanner’s saved protocol list |
| Bolus-tracking ROI misplacement | Placing the tracking ROI outside the true aortic lumen, delaying or missing the trigger | Confirm ROI placement on the scout image before every acquisition; use a consistent celiac-axis level landmark |
| Insufficient flow rate or line gauge | Using a small-bore peripheral line that cannot sustain 4.0 mL/s, producing a fragmented or delayed bolus | Verify line gauge (18G or larger) and patency with a saline test injection prior to the contrast bolus |
| Fixed delay miscalculation | Timing the 70-second portal venous phase from trigger detection rather than injection start | Standardize timing protocols to begin the countdown at the moment the injector starts, not at bolus-tracking trigger |
| Patient motion between phases | Breathing or positional shift causing slice misregistration that mimics lesion migration | Coach consistent breath-hold instructions identically across all three phases |
Pitfalls — Radiologists’ Perspective
The primary interpretation pitfall in CT gastrointestinal bleed reporting is misreading high-density contrast or pooled retained fluid within a small bowel loop as active intraluminal bleeding when only a single phase is available for review. Without the temporal context of a non-contrast baseline and a comparison portal venous phase, a static pool of dense material can be indistinguishable from genuinely extravasating contrast.
| Pitfall | Mechanism | Consequence | Mitigation |
|---|---|---|---|
| False-positive bleed on single-phase review | Retained dense fluid, ingested high-density material, or normal mural enhancement misinterpreted without baseline comparison | Unnecessary emergent angiography or surgery; patient exposed to additional procedural risk | Always review all three phases side by side before finalizing a positive call; confirm the finding was absent at baseline and evolved on the venous phase |
| Missed intermittent bleeding | Bleeding paused at the moment of scanning despite a recent significant hemorrhagic episode | False reassurance, delayed definitive treatment | Correlate with clinical trajectory (hemoglobin trend, hemodynamics); recommend repeat imaging or tagged RBC scan if clinical suspicion remains high despite a negative CT |
| Confusing a sentinel clot for the bleeding site itself | Hemoperitoneum or pericolonic hematoma adjacent to, but not precisely at, the true vascular source | Interventional radiology targets the wrong arterial branch | Trace findings to the specific bowel segment and named vessel rather than the location of associated hematoma alone |
| Underestimating variceal versus arterial source | Venous-pattern bleeding misclassified as arterial due to insufficient attention to portal venous phase morphology | Inappropriate referral for arterial embolization rather than TIPS or endoscopic banding | Specifically characterize vessel morphology (serpiginous and venous versus focal arterial blush) in every report |
Pitfalls — Non-Radiology Physicians’ Perspective
| Pitfall | What They See | What It Actually Is | Clinical Danger | What to Do |
|---|---|---|---|---|
| Treating a “negative CT” as a definitive negative for bleeding | A formal report stating no active extravasation identified | A snapshot of a typically intermittent process; bleeding may simply have paused during the scan window | False reassurance leading to premature discharge or delayed re-evaluation | Continue clinical monitoring (hemoglobin trend, vital signs) regardless of CT result; escalate to endoscopy or repeat imaging if bleeding recurs |
| Equating “diverticulosis” with the bleeding source | Multiple diverticula noted in the report alongside a separate focus of extravasation | Diverticulosis is extremely common and frequently incidental; the true source may be elsewhere | Misdirected endoscopic or surgical intervention at the wrong segment | Confirm the radiologist has explicitly localized the active extravasation to a specific diverticulum, not simply noted diverticular disease in general |
| Ordering CT before adequate resuscitation | An unstable patient sent to CT prior to volume or blood product resuscitation | Hypotension reduces contrast bolus transit and arterial opacification, lowering test sensitivity | A technically suboptimal, falsely negative study in the sickest patients | Stabilize hemodynamics where feasible before transport; communicate instability to the radiology team so technique can be adapted |
| Overlooking the renal function safety window | An urgent request for contrast CT without a recent creatinine | Contrast-induced nephropathy risk in patients with unrecognized chronic kidney disease | Avoidable renal injury layered onto an already critically ill patient | Obtain or estimate eGFR where time permits; document the risk-benefit discussion when bypassing this step in true emergencies |
Bridge the Gap Between Ordering and Interpreting Teams
Shared protocol education reduces miscommunication between emergency, surgical, and radiology teams.
Pitfall Comparison Summary
🟡 Scanning (Radiographers)
Omitting the non-contrast baseline phase, leaving no reference point to exclude retained high-density mimics from true active extravasation.
🔴 Interpretation (Radiologists)
Misreading pooled high-density fluid or retained material as active bleeding when reviewing a single phase in isolation, without temporal comparison.
🟣 Clinical (Physicians)
Treating a single negative CT as definitive given the intermittent nature of gastrointestinal hemorrhage, leading to premature reassurance.
AI & Automation in GI Bleed Imaging
Artificial intelligence tools for gastrointestinal hemorrhage detection are an active area of clinical development, with FDA-cleared and CE-marked computer-aided detection algorithms increasingly available for triaging CT and angiographic studies for active extravasation. Published work has demonstrated that convolutional neural network models trained on labeled angiographic and cross-sectional datasets can achieve strong sensitivity and specificity for identifying active bleeding foci, with one recent study reporting high area-under-the-curve performance for distinguishing bleeding from non-bleeding angiographic images[8]. In the CT domain specifically, automated bolus-tracking software, AI-assisted bowel-wall segmentation, and worklist prioritization tools that flag studies containing a suspected high-attenuation extraluminal focus are being integrated into PACS workflows to shorten the time between image acquisition and interventional radiology notification.
These tools are best understood as triage and quality-assurance aids rather than autonomous diagnostic replacements: an AI flag for possible extravasation should prompt expedited radiologist review of the multiphase comparison, not a bypass of that review. Evidence-based adoption requires institutions to validate any AI tool against their own scanner protocols, patient population, and the specific three-phase workflow described in this article before relying on it in time-critical decision-making.
Accelerate Time-to-Detection in Your GI Bleed Workflow
Explore how automation and standardized injection protocols work together to support faster, more confident calls.
Further Reading
- CT Enterography Protocol: 7 Steps to Spot IBD Fast
- 5 Master Mesenteric CTA Protocol Tactics
- CT Trauma Pan-Scan Protocol: 7 Critical Steps
- Dual-Phase Pancreatic CT Protocol: 7 Critical Steps
- 2026 Contrast Media Guidelines: eGFR Thresholds & Safe Administration Protocol
Conclusion
The CT gastrointestinal bleed protocol succeeds or fails on the discipline of its three-phase architecture. A non-contrast baseline excludes dense mimics; a precisely bolus-tracked arterial phase captures peak-attenuation extravasation; and a 70-second portal venous phase confirms that a candidate focus is genuinely evolving rather than static. Skipping any one of these three pillars — most commonly the non-contrast phase under time pressure — removes the temporal logic that makes this protocol diagnostically trustworthy in the first place.
Across the ten pathologies most frequently encountered, from common diverticular hemorrhage and angiodysplasia to the surgical emergencies of aortoenteric fistula and Dieulafoy’s lesion, accurate detection depends on the same underlying principle: a true positive finding must be absent at baseline, present and intense on the arterial phase, and larger or shifted on the venous phase. The three-tier pitfall framework presented here — a scanning-stage failure to acquire the baseline phase, an interpretation-stage failure to compare phases before calling a positive, and a clinical-stage failure to recognize the intermittent nature of hemorrhage — maps directly onto where errors most commonly enter this diagnostic pathway, and recognizing each tier is the most reliable way to prevent them.
References
- Wells, M. L., Hansel, S. L., Bruining, D. H., Fletcher, J. G., Froemming, A. T., Barlow, J. M., & Fidler, J. L. (2018). CT for evaluation of acute gastrointestinal bleeding. RadioGraphics, 38(4), 1089–1107. https://doi.org/10.1148/rg.2018170138
- Di Serafino, M., Iacobellis, F., Schillirò, M. L., Dell’Aversano Orabona, G., Martino, A., Bennato, R., Borzelli, A., Oliva, G., D’Errico, C., Pezzullo, F., Barbuto, L., Ronza, R., Ponticiello, G., Corvino, F., Giurazza, F., Lombardi, G., Niola, R., & Romano, L. (2022). The role of CT-angiography in the acute gastrointestinal bleeding: A pictorial essay of active and obscure findings. Tomography, 8(5), 2369–2402. https://doi.org/10.3390/tomography8050198
- Spiritos, Z., Horton, A., Parish, A., Niedzwiecki, D., Wilson, G., Kim, C. Y., & Wild, D. (2023). Clinical predictors of a positive CT angiogram study used for the evaluation of acute gastrointestinal hemorrhage. Digestive Diseases and Sciences, 68(1), 181–186. https://doi.org/10.1007/s10620-022-07514-8
- Carney, B. W., Khatri, G., & Shenoy-Bhangle, A. S. (2019). The role of imaging in gastrointestinal bleed. Cardiovascular Diagnosis and Therapy, 9(Suppl 1), S88–S96. https://doi.org/10.21037/cdt.2018.12.07
- Iacobellis, F., Narese, D., Berritto, D., Brillantino, A., Di Serafino, M., Guerrini, S., Grassi, R., Scaglione, M., Mazzei, M. A., & Romano, L. (2021). Large bowel ischemia/infarction: How to recognize it and make differential diagnosis? A review. Diagnostics, 11(6), 998. https://doi.org/10.3390/diagnostics11060998
- European Commission, Directorate-General for Energy. (2018). Radiation Protection N° 185: European guidelines on diagnostic reference levels for paediatric imaging. Publications Office of the European Union. https://op.europa.eu
- International Commission on Radiological Protection. (2021). ICRP Publication 147: Use of dose quantities in radiological protection. ICRP. https://www.icrp.org
- American College of Radiology. (2023). ACR Manual on Contrast Media. American College of Radiology. https://www.acr.org/Clinical-Resources/Contrast-Manual
- American College of Radiology. (2023). ACR Appropriateness Criteria: Radiologic Management of Lower Gastrointestinal Tract Hemorrhage. American College of Radiology. https://www.acr.org/Clinical-Resources/ACR-Appropriateness-Criteria
- Laine, L., Barkun, A. N., Saltzman, J. R., Martel, M., & Leontiadis, G. I. (2021). ACG clinical guideline: Upper gastrointestinal and ulcer bleeding. American Journal of Gastroenterology, 116(5), 899–917. https://journals.lww.com/ajg
- Strate, L. L., & Gralnek, I. M. (2016). ACG clinical guideline: Management of patients with acute lower gastrointestinal bleeding. American Journal of Gastroenterology, 111(4), 459–474. https://journals.lww.com/ajg
- Geffroy, Y., Rodallec, M. H., Boulay-Coletta, I., Jullès, M. C., Ridereau-Zins, C., & Zins, M. (2011). Multidetector CT angiography in acute gastrointestinal bleeding: Why, when, and how. RadioGraphics, 31(3), E35–E46. https://doi.org/10.1148/rg.313105206
- European Society of Gastrointestinal and Abdominal Radiology. (2022). ESGAR Guidelines on Imaging of Acute Gastrointestinal Bleeding. ESGAR. https://www.esgar.org
- European Society of Radiology. (2021). ESR Statement on the Justification of CT Examinations. Insights into Imaging. https://insightsimaging.springeropen.com
- Radiological Society of North America. (2023). RSNA Radiology Information Resource: CT Angiography. RadiologyInfo.org. https://www.radiologyinfo.org
- American Association of Physicists in Medicine. (2018). AAPM Report No. 220: Size-specific dose estimates (SSDE) for computed tomography. AAPM. https://www.aapm.org
- Peery, A. F., Crockett, S. D., Murphy, C. C., Lund, J. L., Dellon, E. S., Williams, J. L., Jensen, E. T., Shaheen, N. J., Barritt, A. S., Lieber, S. R., Kochar, B., Barnes, E. L., Fan, Y. C., Pate, V., Galanko, J., Baron, T. H., & Sandler, R. S. (2019). Burden and cost of gastrointestinal, liver, and pancreatic diseases in the United States: Update 2018. Gastroenterology, 156(1), 254–272. https://doi.org/10.1053/j.gastro.2018.08.063
- Wells, M. L., Anderson, M. A., Fidler, J. L., Naringrekar, H. V., Allen, B. C., & O’Connor, S. (2023). Dual-energy CT evaluation of gastrointestinal bleeding. RadioGraphics, 43(11), e230006. https://pubs.rsna.org/doi/10.1148/rg.230006
- Garg, T., Khorshidi, F., Habibollahi, P., Shrigiriwar, A., Fang, A., Sakiani, S., Harfouche, M., Diaz, J. J., & Nezami, N. (2023). How I do it: Endovascular management of acute nonvariceal gastrointestinal bleeding. Seminars in Interventional Radiology, 40(5), 433–443. https://doi.org/10.1055/s-0043-1776428
- International Commission on Radiological Protection. (2007). ICRP Publication 103: The 2007 Recommendations of the International Commission on Radiological Protection. ICRP. https://www.icrp.org
- European Stroke Organisation. (2022). ESO Imaging Guidelines for Acute Vascular Emergencies. European Stroke Journal. https://journals.sagepub.com/home/eso
- McDonald, J. S., McDonald, R. J., Williamson, E. E., & Kallmes, D. F. (2023). Risk of acute kidney injury following intravenous iodinated contrast media exposure: 2023 update. American Journal of Roentgenology, 221(3), 312–323. https://doi.org/10.2214/AJR.23.30037
- Levin, A., & Stevens, P. E. (2024). Executive summary of the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney International, 105(4), 684–701. https://doi.org/10.1016/j.kint.2023.10.016
- Di Serafino, M., Severino, R., Laviani, F., & Maroscia, D. (2016). Three-dimensional computed tomography rendering of pedunculated colon polyp: New “clapper-bell” sign pedunculated polyp at 3D computed tomography. Radiology Case Reports, 11(4), 292–295. https://doi.org/10.1016/j.radcr.2016.06.004
- Radiological diagnosis of acute mesenteric ischemia in adult patients: A systematic review and meta-analysis. (2025). Scientific Reports, 15, 94846. https://doi.org/10.1038/s41598-025-94846-w
- American College of Radiology. (2024). ACR–SPR Practice Parameter for the Performance of Computed Tomography (CT) of the Abdomen and Pelvis. American College of Radiology. https://www.acr.org
